ESMO 2026 | Dr. Sebastian Kobold on Advancing Cell Therapy for Solid Tumors
At ESMO26, Dr. Sebastian Kobold discusses the challenges and emerging opportunities in next-generation cancer immunotherapy, from overcoming immune resistance to improving the precision of treatment selection.
Focus Clinical Scientist Beijing · 29 Oct 2026 ▶ 11:17